RecruitingPhase 2NCT07260877
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
Sponsor: Ventus Therapeutics U.S., Inc.
Fairport, NY · +14 more sites